The TRIPOD-LLM reporting guideline for studies using large language models
Gallifant, Jack; Afshar, Majid; Ameen, Saleem; Aphinyanaphongs, Yindalon; Chen, Shan; Cacciamani, Giovanni; Demner-Fushman, Dina; Dligach, Dmitriy; Daneshjou, Roxana; Fernandes, Chrystinne; Hansen, Lasse Hyldig; Landman, Adam; Lehmann, Lisa; McCoy, Liam G.; Miller, Timothy; Moreno, Amy; Munch, Nikolaj; Restrepo, David; Savova, Guergana; Umeton, Renato; Gichoya, Judy Wawira; Collins, Gary S.; Moons, Karel G.M.; Celi, Leo A.; Bitterman, Danielle S.
(2025) Nature medicine, volume 31, issue 1, pp. 60 - 69
(Article)
Abstract
Large language models (LLMs) are rapidly being adopted in healthcare, necessitating standardized reporting guidelines. We present transparent reporting of a multivariable model for individual prognosis or diagnosis (TRIPOD)-LLM, an extension of the TRIPOD + artificial intelligence statement, addressing the unique challenges of LLMs in biomedical applications. TRIPOD-LLM provides a comprehensive checklist of
... read more
19 main items and 50 subitems, covering key aspects from title to discussion. The guidelines introduce a modular format accommodating various LLM research designs and tasks, with 14 main items and 32 subitems applicable across all categories. Developed through an expedited Delphi process and expert consensus, TRIPOD-LLM emphasizes transparency, human oversight and task-specific performance reporting. We also introduce an interactive website ( https://tripod-llm.vercel.app/ ) facilitating easy guideline completion and PDF generation for submission. As a living document, TRIPOD-LLM will evolve with the field, aiming to enhance the quality, reproducibility and clinical applicability of LLM research in healthcare through comprehensive reporting.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: General Biochemistry,Genetics and Molecular Biology
ISSN: 1078-8956
Publisher: Nature Research
Note: Publisher Copyright: © The Author(s), under exclusive licence to Springer Nature America, Inc. 2025.
(Peer reviewed)